Chemoinformaics analysis of (3S)-3-BUTYL-4,5-DIHYDRO-3H-2-BENZOFURAN-1-ONE
| Molecular Weight | 192.258 | nRot | 3 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 1 |
| Exact Molecular Weight | 192.115 | nRing | 2 |
| Solubility: LogS | -1.717 | nHRing | 1 |
| Solubility: LogP | 1.448 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 32.3127 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.548 |
| Synth | 2.463 |
| Natural Product Likeliness | 0.044 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.01 |
| CACO-2 | -4.277 |
| MDCK | 0.0000198 |
| BBB | 0.997 |
| PPB | 0.664404 |
| VDSS | 0.914 |
| FU | 0.500861 |
| CYP1A2-inh | 0.89 |
| CYP1A2-sub | 0.937 |
| CYP2c19-inh | 0.165 |
| CYP2c19-sub | 0.862 |
| CYP2c9-inh | 0.022 |
| CYP2c9-sub | 0.751 |
| CYP2d6-inh | 0.056 |
| CYP2d6-sub | 0.817 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.217 |
| CL | 10.821 |
| T12 | 0.837 |
| hERG | 0.039 |
| Ames | 0.099 |
| ROA | 0.032 |
| SkinSen | 0.881 |
| Carcinogencity | 0.72 |
| EI | 0.994 |
| Respiratory | 0.022 |
| NR-Aromatase | 0.067 |
| Antiviral | No |
| Prediction | 0.604737 |